Replacement of hepatitis C virus genotype 1b by genotype 2 over a 10-year period in Venezuela

被引:22
作者
Pujol, Flor H. [1 ]
Loureiro, Carmen L. [1 ]
机构
[1] Inst Venezolano Invest Cient, Mol Virol Lab, CMBC, Caracas 1020A, Venezuela
关键词
hepatitis C virus; genotype changes; posttransfusion hepatitis;
D O I
10.1097/01.mcg.0000248010.55149.ce
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Changes in hepatitis C virus (HCV) genotype distribution with time have been reported in several countries. Goals: To explore eventual changes in HCV genotype distribution in Venezuela over a 10 years period. Study: HCV genotype was determined by direct sequencing of the 5' noncoding region, in 236 isolates circulating in patients treated during years 2005 to 2006. Genotype distribution was compared with the one observed in 43 patients followed during years 1994 to 1996. Results: The prevalence HCV genotype I and 2 was 70% and 26%, respectively, in patients followed during years 1994 to 1996. The frequency of genotype 2 was significantly increased to 41 % (P = 0.04) in patients treated during years 2005 to 2006. A significant reduction in HCV genotype lb prevalence (48% to 27%, P = 0.01) was also observed after this 10 years period, whereas the prevalence of HCV genotype I a did not change over time (22% vs. 27%, NS). Transfusion was more significantly associated with infection with HCV genotype 1b than with other genotypes (52% vs. 20%, P 0.002). Conclusions: HCV subtype lb seems to have been displaced by HCV genotype 2 in a relatively short period, without increase in the frequency of genotype 3. The low frequency of HCV genotype 3 in Venezuela might be due to the fact that intravenous drug use in Venezuela is less common than in other countries. The implementation of anti-HCV testing in blood banks since 1994 in Venezuela, might have contributed to the reduction in the frequency HCV genotype lb infection.
引用
收藏
页码:518 / 520
页数:3
相关论文
共 29 条
  • [1] Aguilar MS, 2001, ANN TROP MED PARASIT, V95, P187, DOI 10.1080/00034980120042944
  • [2] The prevalence of hepatitis C virus infection in the United States, 1988 through 1994
    Alter, MJ
    Kruszon-Moran, D
    Nainan, OV
    McQuillan, GM
    Gao, FX
    Moyer, LA
    Kaslow, RA
    Margolis, HS
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (08) : 556 - 562
  • [3] Hepatitis C virus (HCV) genotypes in 373 Italian children with HCV infection: changing distribution and correlation with clinical features and outcome
    Bortolotti, F
    Resti, M
    Marcellini, M
    Giacchino, R
    Verucchi, G
    Nebbia, G
    Zancan, L
    Marazzi, MG
    Barbera, C
    Maccabruni, A
    Zuin, G
    Maggiore, G
    Balli, F
    Vajro, P
    Lepore, L
    Molesini, M
    Guido, M
    Bartolacci, S
    Noventa, F
    [J]. GUT, 2005, 54 (06) : 852 - 857
  • [4] Hepatitis viruses: Their role in human cancer
    Bradley, DW
    [J]. PROCEEDINGS OF THE ASSOCIATION OF AMERICAN PHYSICIANS, 1999, 111 (06) : 588 - 593
  • [5] Reduced antibody reactivity to hepatitis C virus antigens in hemodialysis patients coinfected with hepatitis B virus
    Devesa, M
    Khudyakov, YE
    Capriles, F
    Blitz, L
    Fields, HA
    Liprandi, F
    Pujol, FH
    [J]. CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1997, 4 (06) : 639 - 642
  • [6] Echevarría JM, 2006, ENFERM INFEC MICR CL, V24, P20
  • [7] Echevarría José M., 2003, Cad. Saúde Pública, V19, P1583, DOI 10.1590/S0102-311X2003000600003
  • [8] Lavanchy D, 1999, J VIRAL HEPATITIS, V6, P35
  • [9] Population genetic history of hepatitis C virus 1b infection in China
    Nakano, T
    Lu, L
    He, YS
    Fu, YS
    Robertson, BH
    Pybus, OG
    [J]. JOURNAL OF GENERAL VIROLOGY, 2006, 87 : 73 - 82
  • [10] HCV:: epidemiology, modes of transmission and prevention of spread
    Pradat, P
    Trépo, C
    [J]. BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2000, 14 (02) : 201 - 210